http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007054288-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c98d8879ddbf1240cfac49d44d067f8b |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30 |
filingDate | 2005-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa15e0e44b9ebddacb38e5e06ec1579e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e76183584faeb19e83aa545607fb51bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49968f4d3112e3b50951909b0c402073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f553e42a646bb66c1c99d60e730a4ae2 |
publicationDate | 2007-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2007054288-A |
titleOfInvention | Composition for iontophoresis and electrode structure |
abstract | To provide a composition for iontophoresis and an electrode structure for transdermally administering a drug stably while maintaining a high transportation number. An iontophoresis composition containing an ionic drug A and a nonionic pharmaceutical additive B, and an electrode structure holding the composition, wherein the pharmaceutical additive is nonionic Therefore, when energized, movement of the ionic drug by electrophoresis is not hindered, and a high transport number of the ionic drug is ensured, and when the current is not energized, the physicochemical state of the ionic drug is stabilized. The nonionic pharmaceutical additive consists of methyl paraben, chlorobutanol, isobutyl paraoxybenzoate, isopropyl paraoxybenzoate, ethyl paraoxybenzoate, butyl paraoxybenzoate, propyl paraoxybenzoate, methyl paraoxybenzoate and D-sorbitol tol At least one selected from the group. [Selection] Figure 2 |
priorityDate | 2005-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.